Renaissance Group’s MiMedx Group MDXG Stock Holding History

Renaissance Group’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-31,541	Closed	-$398K	–	298
2017 Q4	$398K	Buy	+31,541	New	+$385K	0.01%	230

Other funds holding MDXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Group's MDXG Position: Q1 2018 in Review

Renaissance Group sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 31,541 shares — an estimated $398K sold.

Renaissance Group first reported a position in MDXG in Q4 2017 and held it in 1 quarter. The position peaked at $398K in Q4 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

Renaissance Group reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
Renaissance Group sold 31,541 MiMedx Group shares in Q1 2018, an estimated $398K.
Renaissance Group first reported a position in MiMedx Group in Q4 2017 and held it in 1 quarter.
Renaissance Group's MiMedx Group position peaked at $398K in Q4 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on Renaissance Group's 13F filing for Q1 2018, filed 30 Apr 2018.